Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#403 most reported symptom for this vaccine
Mucous stools has been reported 69 times in association with Hepatitis B (Engerix-B) vaccination in VAERS. This represents 0.1% of all 73,280 reports for this vaccine.
Among these reports, 1 mentioned death (1.45%) and 10 involved hospitalization (14.5%).
Mucous stools is the #403 most frequently reported symptom for Hepatitis B (Engerix-B) out of 2382 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 69 reports of Mucous stools after Hepatitis B (Engerix-B) vaccination may seem alarming, but context is critical.
The mortality rate of 1.45% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.